<p><strong> </strong><strong>Clinicians should not recommend whole gland or focal ablation for patients with high-risk prostate cancer outside of a clinical trial. <em>(Expert Opinion)</em></strong></p>
Discussion
Discussion
<p>Currently, patients being considered for ablation should have intermediate-risk prostate cancer.<sup>146</sup> Patients with high-risk disease should not be recommended ablative techniques due to lack of evidence and risk of missing or delaying definitive approaches with proven benefit.</p>